Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating Myocardium

Ischemic heart disease affects millions of people around the world. Current treatment options, including coronary artery bypass grafting, do not result in full functional recovery, highlighting the need for novel adjunctive therapeutic approaches. Hibernation describes the myocardial response to pro...

Full description

Bibliographic Details
Main Authors: Rishav Aggarwal, Koray N. Potel, Edward O. McFalls, Tammy A. Butterick, Rosemary F. Kelly
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/11/11/2155
_version_ 1797469279644286976
author Rishav Aggarwal
Koray N. Potel
Edward O. McFalls
Tammy A. Butterick
Rosemary F. Kelly
author_facet Rishav Aggarwal
Koray N. Potel
Edward O. McFalls
Tammy A. Butterick
Rosemary F. Kelly
author_sort Rishav Aggarwal
collection DOAJ
description Ischemic heart disease affects millions of people around the world. Current treatment options, including coronary artery bypass grafting, do not result in full functional recovery, highlighting the need for novel adjunctive therapeutic approaches. Hibernation describes the myocardial response to prolonged ischemia and involves a set of complex cytoprotective metabolic and functional adaptations. PGC1-alpha, a key regulator of mitochondrial energy metabolism and inhibitor of oxidant-stress-inflammatory signaling, is known to be downregulated in hibernating myocardium. PGC1-alpha is a critical component of cellular stress responses and links cellular metabolism with inflammation in the ischemic heart. While beneficial in the acute setting, a chronic state of hibernation can be associated with self-perpetuating oxidant stress-inflammatory signaling which leads to tissue injury. It is likely that incomplete functional recovery following revascularization of chronically ischemic myocardium is due to persistence of metabolic changes as well as prooxidant and proinflammatory signaling. Enhancement of PGC1-alpha signaling has been proposed as a possible way to improve functional recovery in patients with ischemic heart disease. Adjunctive mesenchymal stem cell therapy has been shown to induce PGC1-alpha signaling in hibernating myocardium and could help improve clinical outcomes for patients undergoing bypass surgery.
first_indexed 2024-03-09T19:19:08Z
format Article
id doaj.art-7746e8bae0e24f76a2e033d472e6d541
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T19:19:08Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-7746e8bae0e24f76a2e033d472e6d5412023-11-24T03:30:06ZengMDPI AGAntioxidants2076-39212022-10-011111215510.3390/antiox11112155Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating MyocardiumRishav Aggarwal0Koray N. Potel1Edward O. McFalls2Tammy A. Butterick3Rosemary F. Kelly4Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN 55455, USASchool of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast BT9 7BL, UKDivision of Cardiology, Richmond VA Medical Center, Richmond, VA 23249-4915, USADepartment of Neuroscience, University of Minnesota, Minneapolis, MN 55455, USADivision of Cardiothoracic Surgery, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN 55455, USAIschemic heart disease affects millions of people around the world. Current treatment options, including coronary artery bypass grafting, do not result in full functional recovery, highlighting the need for novel adjunctive therapeutic approaches. Hibernation describes the myocardial response to prolonged ischemia and involves a set of complex cytoprotective metabolic and functional adaptations. PGC1-alpha, a key regulator of mitochondrial energy metabolism and inhibitor of oxidant-stress-inflammatory signaling, is known to be downregulated in hibernating myocardium. PGC1-alpha is a critical component of cellular stress responses and links cellular metabolism with inflammation in the ischemic heart. While beneficial in the acute setting, a chronic state of hibernation can be associated with self-perpetuating oxidant stress-inflammatory signaling which leads to tissue injury. It is likely that incomplete functional recovery following revascularization of chronically ischemic myocardium is due to persistence of metabolic changes as well as prooxidant and proinflammatory signaling. Enhancement of PGC1-alpha signaling has been proposed as a possible way to improve functional recovery in patients with ischemic heart disease. Adjunctive mesenchymal stem cell therapy has been shown to induce PGC1-alpha signaling in hibernating myocardium and could help improve clinical outcomes for patients undergoing bypass surgery.https://www.mdpi.com/2076-3921/11/11/2155PGC1-alphaoxidative stressNF-κBhibernating myocardiummitochondrial metabolismmesenchymal stem cell
spellingShingle Rishav Aggarwal
Koray N. Potel
Edward O. McFalls
Tammy A. Butterick
Rosemary F. Kelly
Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating Myocardium
Antioxidants
PGC1-alpha
oxidative stress
NF-κB
hibernating myocardium
mitochondrial metabolism
mesenchymal stem cell
title Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating Myocardium
title_full Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating Myocardium
title_fullStr Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating Myocardium
title_full_unstemmed Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating Myocardium
title_short Novel Therapeutic Approaches Enhance PGC1-alpha to Reduce Oxidant Stress-Inflammatory Signaling and Improve Functional Recovery in Hibernating Myocardium
title_sort novel therapeutic approaches enhance pgc1 alpha to reduce oxidant stress inflammatory signaling and improve functional recovery in hibernating myocardium
topic PGC1-alpha
oxidative stress
NF-κB
hibernating myocardium
mitochondrial metabolism
mesenchymal stem cell
url https://www.mdpi.com/2076-3921/11/11/2155
work_keys_str_mv AT rishavaggarwal noveltherapeuticapproachesenhancepgc1alphatoreduceoxidantstressinflammatorysignalingandimprovefunctionalrecoveryinhibernatingmyocardium
AT koraynpotel noveltherapeuticapproachesenhancepgc1alphatoreduceoxidantstressinflammatorysignalingandimprovefunctionalrecoveryinhibernatingmyocardium
AT edwardomcfalls noveltherapeuticapproachesenhancepgc1alphatoreduceoxidantstressinflammatorysignalingandimprovefunctionalrecoveryinhibernatingmyocardium
AT tammyabutterick noveltherapeuticapproachesenhancepgc1alphatoreduceoxidantstressinflammatorysignalingandimprovefunctionalrecoveryinhibernatingmyocardium
AT rosemaryfkelly noveltherapeuticapproachesenhancepgc1alphatoreduceoxidantstressinflammatorysignalingandimprovefunctionalrecoveryinhibernatingmyocardium